Topic Hub

Amlodipine — Regulatory History

4 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.

4articles

31keywords mapped

2026-05-26latest review

Explore

Amlodipine — Regulatory History library

Showing 4 of 4 clinical reviews.

Clinical Reviews2026-05-26

Amlodipine Compounding Legal Status: FDA Approval, Label Requirements, and Pharmacy Rules

A clinical guide to amlodipine's FDA approval history, current compounding regulations, label requirements, and what prescribers and patients need to know about legally obtaining this calcium channel blocker.

Read clinical review

Safety2026-05-27

Amlodipine FDA Approval History: Timeline, Label Changes, and Post-Market Safety

A complete timeline of amlodipine's FDA approval, label updates, generic entry, and post-market safety data from 1987 NDA filing through 2026.

Read clinical review

Safety2026-05-26

Amlodipine Label Updates 2020 to 2026: FDA Safety Changes, New Warnings, and What Clinicians Need to Know

A comprehensive review of every FDA label revision for amlodipine besylate from 2020 through 2026, including new safety warnings, updated drug interactions, and post-market surveillance findings.

Read clinical review

Safety2026-05-26

Amlodipine Legal & Patent Challenges: FDA History, Generic Entry, and Post-Market Safety

A complete regulatory history of amlodipine (Norvasc), covering FDA approval, patent litigation, generic entry, labeling updates, and ongoing post-market surveillance.

Read clinical review